Bat biotech takes flight
Elie Dolgin • July 17, 2023
Harnessing the unusual biology of bats, researchers aim to turn drug discovery upside-down.
Bats have faced intense scrutiny as a source of deadly viruses, including the one that unleashed the recent global pandemic. Yet amidst their maligned reputation lies a captivating paradox: the very traits that make bats reservoirs of viral infections also render them potential allies in the pursuit of new drug targets.
Continue reading at Nature Biotechnology.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.